Lead Product(s): GEM103
Therapeutic Area: Ophthalmology Product Name: Undisclosed
Highest Development Status: Phase I Product Type: Large molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable January 09, 2020
The company looking forward to topline data from this study and the potential to initiate a Phase 2 study supported by the CLARITY natural history study data.